Skip to main content

Table 4 Association between CRP levels and high MDA-LDL level in univariate and multivariate logistic analyses

From: Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease

 

CRP concentration, mg/dL

 
 

<0.1

0.1–0.2

≥0.2

p*

Univariate, OR (95% CI)

1

1.77 (0.89–3.55)

3.40 (1.54–8.02)

0.006

Multivariate, OR (95% CI)

    

 Adjusted for LDL-C

1

1.43 (0.68–3.01)

3.44 (1.49–8.45)

0.014

 Adjusted for LDL-C, TG

1

1.08 (0.49–2.35)

2.74 (1.14–6.95)

0.071

 Adjusted for LDL-C, TG, HDL-C

1

0.95 (0.42–2.09)

2.41 (0.98–6.20)

0.124

  1. Abbreviations: CI confidence interval, CRP C-reactive protein, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, MDA-LDL malondialdehyde-modified LDL, OR odds ratio; TG triglycerides.
  2. Univariate and multivariate logistic analyses with an adjustment for the indicated parameters were performed. A high MDA-LDL level was defined by a median value of >91 U/L.
  3. *Likelihood ratio test for trend.